Cargando…
Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer
BACKGROUND: Monomeric laminin-γ2 in urine is a potential biomarker for bladder cancer. However, the current detection system uses an antibody that cannot discriminate between monomeric laminin-γ2 and the heterotrimeric γ2 chain of laminin-332, which may cause false-positive reactions. The present st...
Autores principales: | Nakagawa, Masatoshi, Karashima, Takashi, Kamada, Masayuki, Yoshida, Eisaku, Yoshimura, Toru, Nojima, Masanori, Inoue, Keiji, Shuin, Taro, Seiki, Motoharu, Koshikawa, Naohiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640956/ https://www.ncbi.nlm.nih.gov/pubmed/29046806 http://dx.doi.org/10.1186/s40364-017-0109-4 |
Ejemplares similares
-
Urinary laminin‐γ2 is a novel biomarker of non‐muscle invasive urothelial carcinoma
por: Kamada, Masayuki, et al.
Publicado: (2015) -
Unique Biological Activity and Potential Role of Monomeric Laminin-γ2 as a Novel Biomarker for Hepatocellular Carcinoma: A Review
por: Yasuda, Hiroshi, et al.
Publicado: (2019) -
Clinical evaluation of urine laminin‐γ2 monomer as a potent biomarker for non‐muscle invasive bladder cancer
por: Karashima, Takashi, et al.
Publicado: (2022) -
Serum monomeric laminin‐γ2 as a novel biomarker for hepatocellular carcinoma
por: Kiyokawa, Hirofumi, et al.
Publicado: (2017) -
EphA2 Proteolytic Fragment as a Sensitive Diagnostic Biomarker for Very Early-stage Pancreatic Ductal Carcinoma
por: Sato, Shinya, et al.
Publicado: (2023)